Abstract:The in vitro dissolution mechanism of an amorphous solid dispersion (ASD) remains elusive and highly individualized, yet rational design of ASDs with optimal performance and prediction of their in vitro/in vivo performance are very much desirable in the pharmaceutical industry. To this end, we carried out comprehensive investigation of various ASD systems of griseofulvin, felodipine, and ketoconazole, in PVP-VA or HPMC-AS at different drug loading. Physiochemical properties and processes related to drug-polymer-water interaction, including the drug crystallization tendency in aqueous medium, drug-polymer interaction before and after moisture exposure, supersaturation of drug in the presence of polymer, polymer dissolution kinetics, etc., were characterized and correlated with the dissolution performance of ASDs at different dose and different drug/polymer ratio. It was observed that ketoconazole/HPMC-AS ASD outperformed all other ASDs in various dissolution conditions, which was attributed to the drugs low crystallization tendency, the strong ketoconazole/HPMC-AS interaction and the robustness of this interaction against water disruption, the dissolution rate and the availability of HPMC-AS in solution, and the ability of HPMC-AS in maintaining ketoconazole supersaturation. It was demonstrated that all these properties have implications for the dissolution performance of various ASD systems, and further quantification of them could be used as potential predictors for in vitro dissolution of ASDs. For all ASDs investigated, HPMC-AS systems performed better than, or at least comparably with, their PVP-VA counterparts, regardless of the drug loading or dose. This observation cannot be solely attributed to the ability of HPMC-AS in maintaining drug supersaturation. We also conclude that, for fast crystallizers without strong drug-polymer interaction, the only feasible option to improve dissolution might be to lower the dose and the drug loading in the ASD. In this study, we implemented an ASD/water Flory-Huggins parameter plot, which might assist in revealing the physical nature of the drug-polymer interaction. We also introduced supersaturation parameter and dissolution performance parameter as two quantitative measurements to compare the abilities of polymers in maintaining drug supersaturation, and the dissolution performance of various solid dispersions, respectively.

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

Stability of Nanosuspensions in Drug Delivery

Stability and Controlling Strategies in Particle Size of Nanosuspension

Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques

Multi-directionally Evaluating the Formation Mechanism of 1,4-Dihydropyridine Drug Nanosuspensions Through Experimental Validation and Computer-Aided Drug Design.

Quantitative Analysis of Physical Stability Mechanisms of Amorphous Solid Dispersions by Molecular Dynamic Simulation

Preparation and Optimization of Resveratrol Nanosuspensions by Antisolvent Precipitation Using Box-Behnken Design

Food Proteins As Novel Nanosuspension Stabilizers for Poorly Water-Soluble Drugs

A Controlling Method For Agi Nanoparticles Preparation Using Combinatorial Surfactants

Spatial-thermodynamic Understanding of Stabilization Mechanism Using Computational Approaches and Molecular-Level Elucidation of the Mechanism of Crystal Transformation in Polymorphic Irbesartan Nanosuspensions.

Formulating Food Protein-Stabilized Indomethacin Nanosuspensions into Pellets by Fluid-Bed Coating Technology: Physical Characterization, Redispersibility, and Dissolution

Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine

Polymer-Mediated Drug Supersaturation Controlled by Drug–Polymer Interactions Persisting in an Aqueous Environment

Influence of Intermolecular Interactions on Crystallite Size in Crystalline Solid Dispersions

Spray drying of monodispersed microencapsulates: implications of formulation and process parameters on microstructural properties and controlled release functionality.

Controlled Formation and Stabilization of Nanosized Colloidal Suspensions by Combination of Soy Protein and Biosurfactant Stevioside As Stabilizers

Size Control of Drug Nanoparticles Stabilized by Mpeg-B-pcl During Flash Nanoprecipitation

Drug-polymer Solubility and Miscibility: Stability Consideration and Practical Challenges in Amorphous Solid Dispersion Development.

Development and in Vitro Characterizations of Bifendate Nanosuspensions.

Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.

Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and in Vitro Performance